Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC386911830;11831;11832 chr2:178741628;178741627;178741626chr2:179606355;179606354;179606353
N2AB355210879;10880;10881 chr2:178741628;178741627;178741626chr2:179606355;179606354;179606353
N2ANoneNone chr2:Nonechr2:None
N2B350610741;10742;10743 chr2:178741628;178741627;178741626chr2:179606355;179606354;179606353
Novex-1363111116;11117;11118 chr2:178741628;178741627;178741626chr2:179606355;179606354;179606353
Novex-2369811317;11318;11319 chr2:178741628;178741627;178741626chr2:179606355;179606354;179606353
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTT
  • RefSeq wild type template codon: CAA
  • Domain: Ig-27
  • Domain position: 50
  • Structural Position: 125
  • Q(SASA): 0.5136
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/L rs747929496 -0.079 0.9 N 0.324 0.199 None gnomAD-2.1.1 4.02E-06 None None None None I None 0 0 None 0 0 None 0 None 0 8.9E-06 0
V/L rs747929496 -0.079 0.9 N 0.324 0.199 None gnomAD-4.0.0 7.52617E-06 None None None None I None 0 0 None 0 0 None 0 0 8.99457E-06 0 1.65667E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.4007 ambiguous 0.3414 ambiguous -0.657 Destabilizing 0.948 D 0.457 neutral N 0.501358566 None None I
V/C 0.8236 likely_pathogenic 0.8215 pathogenic -0.654 Destabilizing 1.0 D 0.649 neutral None None None None I
V/D 0.6423 likely_pathogenic 0.5993 pathogenic -0.327 Destabilizing 0.999 D 0.748 deleterious N 0.505100264 None None I
V/E 0.5871 likely_pathogenic 0.5391 ambiguous -0.415 Destabilizing 0.999 D 0.726 prob.delet. None None None None I
V/F 0.2887 likely_benign 0.249 benign -0.684 Destabilizing 0.994 D 0.688 prob.neutral N 0.510971288 None None I
V/G 0.4959 ambiguous 0.4364 ambiguous -0.84 Destabilizing 0.999 D 0.742 deleterious D 0.570702888 None None I
V/H 0.7511 likely_pathogenic 0.7167 pathogenic -0.337 Destabilizing 1.0 D 0.713 prob.delet. None None None None I
V/I 0.0967 likely_benign 0.0896 benign -0.311 Destabilizing 0.198 N 0.19 neutral N 0.502297159 None None I
V/K 0.6463 likely_pathogenic 0.5915 pathogenic -0.594 Destabilizing 0.999 D 0.729 prob.delet. None None None None I
V/L 0.2946 likely_benign 0.2514 benign -0.311 Destabilizing 0.9 D 0.324 neutral N 0.482808783 None None I
V/M 0.3122 likely_benign 0.2596 benign -0.359 Destabilizing 0.998 D 0.567 neutral None None None None I
V/N 0.5575 ambiguous 0.4905 ambiguous -0.325 Destabilizing 0.999 D 0.745 deleterious None None None None I
V/P 0.9386 likely_pathogenic 0.9122 pathogenic -0.39 Destabilizing 0.999 D 0.711 prob.delet. None None None None I
V/Q 0.6056 likely_pathogenic 0.5557 ambiguous -0.546 Destabilizing 0.999 D 0.708 prob.delet. None None None None I
V/R 0.5042 ambiguous 0.4772 ambiguous -0.062 Destabilizing 0.999 D 0.74 deleterious None None None None I
V/S 0.4075 ambiguous 0.3531 ambiguous -0.744 Destabilizing 0.999 D 0.659 neutral None None None None I
V/T 0.406 ambiguous 0.3541 ambiguous -0.726 Destabilizing 0.992 D 0.489 neutral None None None None I
V/W 0.9231 likely_pathogenic 0.9129 pathogenic -0.775 Destabilizing 1.0 D 0.683 prob.neutral None None None None I
V/Y 0.7163 likely_pathogenic 0.6958 pathogenic -0.488 Destabilizing 0.999 D 0.677 prob.neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.